Literature DB >> 3396220

Role of IgM-rheumatoid factor interference in the determination of total serum IgE and IgE-containing circulating immune complexes.

L S De Clerck1, P L Gigase, C H Bridts, W J Stevens.   

Abstract

IgM-rheumatoid factor (RF) interference in the determination of total serum IgE and IgE-containing circulating immune complexes (IgE-CIC) was studied by inhibition experiments in vitro comparing a new ELISA technique free of IgM-RF interference with more widely used RIA methods. It was shown that a considerable overestimation of the IgE content in CIC can exist when high levels of IgM-RF are present in the same serum. The clinical part of this study revealed a dramatic fall in prevalence of IgE-CIC in patients with rheumatoid arthritis (RA) with the ELISA technique, compared with the more conventional RIA method (respectively 1/20 compared to 12/20 positive for IgE-CIC). In these patients, there was a good correlation between the level of IgM-RF and the amount of IgE detected in the CIC by the RIA method (r = 0.87) whereas the RF-interference free ELISA method showed no correlation between these two parameters (r = 0.06). Total serum IgE determination with a solid phase RIA was also influenced by IgM-RF interference, whereas the PRIST method was not affected by the presence of IgM-RF. In conclusion, in patients with rheumatic diseases, IgE-assays using polyclonal rabbit or sheep anti-IgE antibodies are not appropriate and monoclonal anti-IgE antibodies that have been proved not to interfere with IgM-RF should be advocated.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3396220      PMCID: PMC1541509     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  Serum IgE concentrations in rheumatoid arthritis: lack of correlation with gold toxicity.

Authors:  D M Grennan; D G Palmer
Journal:  Br Med J       Date:  1979-12-08

3.  IgE class immune complexes in Felty's syndrome: characterisation of antibody activities in isolated complexes.

Authors:  K Merétey; A Falus; U Böhm; H Permin; A Wiik
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

4.  Immunoglobulin E (IgE) levels in serum and synovial fluid in rheumatoid arthritis.

Authors:  G G Hunder; G J Gleich
Journal:  Arthritis Rheum       Date:  1974 Nov-Dec

5.  Radioimmune double PEG precipitation technique for detecting complexed IgE.

Authors:  K Meretey; U Böhm; A Falus; S Bozsoky
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

6.  Use of monoclonal antibodies and F(ab')2 enzyme conjugates in ELISA for IgM, IgA and IgG rheumatoid factors.

Authors:  I Teitsson; H Valdimarsson
Journal:  J Immunol Methods       Date:  1984-07-06       Impact factor: 2.303

7.  Phagocytosis by normal polymorphonuclear leukocytes of immune complexes from serum of patients with Felty's syndrome and rheumatoid arthritis with special reference to IgE immune complexes.

Authors:  H Permin; A Wiik; R Djurup
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1984-02

8.  IgE and IgE-rheumatoid factors in circulating immune complexes in rheumatoid arthritis.

Authors:  K Meretey; A Falus; C C Erhardt; R N Maini
Journal:  Ann Rheum Dis       Date:  1982-08       Impact factor: 19.103

9.  IgE deposition in normal skin of patients with rheumatoid arthritis in relation to clinical and laboratory findings.

Authors:  L S De Clerck; M L Westedt; A Cats; B J Vermeer; E F Weltevreden; C H Bridts; W J Stevens
Journal:  Ann Rheum Dis       Date:  1985-11       Impact factor: 19.103

10.  IgG-containing and IgE-containing circulating immune complexes in patients with asthma and rhinitis.

Authors:  W J Stevens; C H Bridts
Journal:  J Allergy Clin Immunol       Date:  1984-02       Impact factor: 10.793

View more
  4 in total

1.  High IgE in rheumatoid arthritis (RA) patients is complexed with anti-IgE autoantibodies.

Authors:  N Millauer; A W Zuercher; S M Miescher; H A Gerber; M Seitz; B M Stadler
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

2.  Antisera to human IgE can also recognize IgA and IgM molecules as produced by selected B lymphoblastoid cell lines.

Authors:  R W Hendriks; A Thompson; M E Kraakman; A L Drayer; R K Schuurman
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

3.  Natural killer cell activity in Sjögren's syndrome and systemic lupus erythematosus: stimulation with interferons and interleukin-2 and correlation with immune complexes.

Authors:  N J Struyf; H W Snoeck; C H Bridts; L S De Clerck; W J Stevens
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

4.  Soluble histocompatibility antigens in synovial fluids of patients with rheumatoid arthritis.

Authors:  F K Stevenson; W A Douglass; M B Spellerberg; M T Walters; M I Cawley
Journal:  Clin Exp Immunol       Date:  1990-04       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.